Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Dec 15;61 Suppl 7(Suppl 7):S733-7.
doi: 10.1093/cid/civ849.

The Potential Role of Mycotoxins as a Contributor to Stunting in the SHINE Trial

Laura E Smith  1 , Andrew J Prendergast  2 , Paul C Turner  3 , Mduduzi N N Mbuya  4 , Kuda Mutasa  5 , George Kembo  6 , Rebecca J Stoltzfus  1 ; Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team
Affiliations
Clinical Trial

The Potential Role of Mycotoxins as a Contributor to Stunting in the SHINE Trial

Laura E Smith et al. Clin Infect Dis. .

Abstract

Children in developing countries experience multiple exposures that are harmful to their growth and development. An emerging concern is frequent exposure to mycotoxins that contaminate a wide range of staple foods, including maize and groundnuts. Three mycotoxins are suspected to contribute to poor child health and development: aflatoxin, fumonisin, and deoxynivalenol. We summarize the evidence that mycotoxin exposure is associated with stunting, and propose that the causal pathway may be through environmental enteric dysfunction (EED) and disturbance of the insulin-like growth factor 1 (IGF-1) axis. The objectives of this substudy are to assess the relationship between agricultural and harvest practices and mycotoxin exposure; to evaluate associations between mycotoxin exposure and child stunting; and to investigate EED as a potential pathway linking mycotoxin exposure to child stunting, to inform potential areas for intervention.

Keywords: aflatoxin; deoxynivalenol; fumonisin; mycotoxin; stunting.

PubMed Disclaimer

References

    1. Turner PC, Flannery B, Isitt C, Ali M, Pestka J. The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr Res Rev 2012; 25:162–79. - PubMed
    1. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial: rationale, design, and methods. Clin Infect Dis 2015; 61(suppl 7):S685–702. - PMC - PubMed
    1. Prendergast A, Mutasa K, Rukobo S et al. . Assessment of environmental enteric dysfunction in the SHINE trial: methods and challenges. Clin Infect Dis 2015; 61(suppl 7):S726–32. - PMC - PubMed
    1. Prendergast A, Kelly P. Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg 2012; 86:756–63. - PMC - PubMed
    1. Prendergast AJ, Humphrey JH. The stunting syndrome in developing countries. Paediatr Int Child Health 2014; 34:250–65. - PMC - PubMed

Publication types